Sunshine Biopharma (SBFM) Leases (2019 - 2025)
Historic Leases for Sunshine Biopharma (SBFM) over the last 5 years, with Q3 2025 value amounting to $820489.0.
- Sunshine Biopharma's Leases rose 5153.05% to $820489.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $820489.0, marking a year-over-year increase of 5153.05%. This contributed to the annual value of $936037.0 for FY2024, which is 4472.28% up from last year.
- Per Sunshine Biopharma's latest filing, its Leases stood at $820489.0 for Q3 2025, which was up 5153.05% from $892817.0 recorded in Q2 2025.
- Sunshine Biopharma's Leases' 5-year high stood at $936037.0 during Q4 2024, with a 5-year trough of $541468.0 in Q3 2024.
- Over the past 4 years, Sunshine Biopharma's median Leases value was $719594.0 (recorded in 2023), while the average stood at $730545.1.
- As far as peak fluctuations go, Sunshine Biopharma's Leases tumbled by 2069.29% in 2024, and later soared by 5832.33% in 2025.
- Quarter analysis of 4 years shows Sunshine Biopharma's Leases stood at $760409.0 in 2022, then dropped by 14.94% to $646779.0 in 2023, then soared by 44.72% to $936037.0 in 2024, then fell by 12.34% to $820489.0 in 2025.
- Its Leases was $820489.0 in Q3 2025, compared to $892817.0 in Q2 2025 and $900890.0 in Q1 2025.